Viral Gene Therapy Eliminates Prostate Cancer

Viral Gene Therapy Eliminates Prostate Cancer
A new therapy revealed synergism between an engineered “cancer terminator virus” and an experimental drug that aims to destroy primary and metastatic prostate cancer, according to researchers from the Virginia Commonwealth University (VCU). The average survival for those suffering with metastatic, hormone-refractory prostate cancer, despite the available treatments, is no longer than two or three years. Due to the urgent necessity of other effective

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Tagged , , .

Isaura Santos graduated with a BS in Cell and Molecular Biology from Universidade Nova de Lisboa and a MA in Communication, Culture and Information Technologies from University Institute of Lisbon (ISCTE-IUL). Her professional interests include science communication, public awareness of science and communication of science through entertainment.

Leave a Comment

Your email address will not be published. Required fields are marked *